Skip to main content

Gyros, George Washington University, Extend Collaboration on CD-Based Protein Quantitation

NEW YORK, Dec. 17 (GenomeWeb News) - Gyros of Uppsala, Sweden, said today it is extending a collaboration with George Washington University for evaluation of its Bioaffy protein quantitation technology.


Under the collaboration, Benjamin Dickens, an associate research professor at George Washington University will expand his studies on the Bioaffy system from mouse to human samples.


The system, which comprises CD microlaboratories for protein immunoasays, is designed for use of nanoliter-scale samples.


"Preliminary data was very promising and assay development appears to be fast and straightforward, so we are extending the study to human samples and focusing on the potential to monitor multiple analytes in a single sample," Dickens said in a statement.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.